

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive regulation by symbiont of host defense response (GO:0052509) | 5.77233116 |
| 2 | modulation by symbiont of host defense response (GO:0052031) | 5.77233116 |
| 3 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 5.77233116 |
| 4 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 5.77233116 |
| 5 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 5.77233116 |
| 6 | modulation by symbiont of host immune response (GO:0052553) | 5.77233116 |
| 7 | response to muramyl dipeptide (GO:0032495) | 5.10460101 |
| 8 | negative regulation of interleukin-1 beta production (GO:0032691) | 5.00164240 |
| 9 | modulation by symbiont of host cellular process (GO:0044068) | 4.60955542 |
| 10 | response to peptidoglycan (GO:0032494) | 4.36313364 |
| 11 | neutrophil activation involved in immune response (GO:0002283) | 4.34635912 |
| 12 | positive regulation of cellular amide metabolic process (GO:0034250) | 4.20099112 |
| 13 | macrophage activation involved in immune response (GO:0002281) | 4.13865686 |
| 14 | positive regulation of heat generation (GO:0031652) | 4.10218657 |
| 15 | negative regulation of interleukin-1 production (GO:0032692) | 4.06247959 |
| 16 | germinal center formation (GO:0002467) | 4.05023006 |
| 17 | indole-containing compound catabolic process (GO:0042436) | 3.99765439 |
| 18 | indolalkylamine catabolic process (GO:0046218) | 3.99765439 |
| 19 | tryptophan catabolic process (GO:0006569) | 3.99765439 |
| 20 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.98207142 |
| 21 | neutrophil mediated immunity (GO:0002446) | 3.95268763 |
| 22 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 3.93997639 |
| 23 | natural killer cell mediated cytotoxicity (GO:0042267) | 3.88074468 |
| 24 | natural killer cell mediated immunity (GO:0002228) | 3.88074468 |
| 25 | positive regulation of interleukin-1 beta secretion (GO:0050718) | 3.86448633 |
| 26 | regulation of germinal center formation (GO:0002634) | 3.85536959 |
| 27 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.83023268 |
| 28 | NIK/NF-kappaB signaling (GO:0038061) | 3.76999588 |
| 29 | cell adhesion mediated by integrin (GO:0033627) | 3.75118192 |
| 30 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.74782866 |
| 31 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.73478232 |
| 32 | response to host immune response (GO:0052572) | 3.73478232 |
| 33 | DNA deamination (GO:0045006) | 3.67645185 |
| 34 | microglial cell activation (GO:0001774) | 3.61949227 |
| 35 | positive regulation of interleukin-1 secretion (GO:0050716) | 3.58319999 |
| 36 | positive regulation of interferon-alpha production (GO:0032727) | 3.55173655 |
| 37 | B cell homeostasis (GO:0001782) | 3.52226935 |
| 38 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.51894097 |
| 39 | cytokine secretion (GO:0050663) | 3.50853757 |
| 40 | negative regulation of mast cell activation (GO:0033004) | 3.50491466 |
| 41 | regulation of interleukin-1 beta secretion (GO:0050706) | 3.49439912 |
| 42 | indolalkylamine metabolic process (GO:0006586) | 3.47387152 |
| 43 | kynurenine metabolic process (GO:0070189) | 3.45795860 |
| 44 | negative regulation of lipid storage (GO:0010888) | 3.43550531 |
| 45 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.42085384 |
| 46 | regulation of interferon-alpha production (GO:0032647) | 3.41183806 |
| 47 | I-kappaB phosphorylation (GO:0007252) | 3.40478928 |
| 48 | tryptophan metabolic process (GO:0006568) | 3.39724901 |
| 49 | regulation of fever generation (GO:0031620) | 3.37949272 |
| 50 | response to host (GO:0075136) | 3.37550719 |
| 51 | response to host defenses (GO:0052200) | 3.37550719 |
| 52 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.37550719 |
| 53 | positive regulation of T-helper 1 type immune response (GO:0002827) | 3.35968764 |
| 54 | cellular response to virus (GO:0098586) | 3.35047617 |
| 55 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 3.34041152 |
| 56 | regulation of integrin activation (GO:0033623) | 3.33141915 |
| 57 | developmental pigmentation (GO:0048066) | 3.31626843 |
| 58 | positive regulation of interleukin-12 production (GO:0032735) | 3.29563611 |
| 59 | modulation by virus of host process (GO:0019054) | 3.28519042 |
| 60 | regulation of heat generation (GO:0031650) | 3.21395427 |
| 61 | detection of biotic stimulus (GO:0009595) | 3.21311934 |
| 62 | wound healing, spreading of epidermal cells (GO:0035313) | 3.20325089 |
| 63 | positive regulation of prostaglandin secretion (GO:0032308) | 3.20053295 |
| 64 | protein K11-linked deubiquitination (GO:0035871) | 3.18276695 |
| 65 | neural tube formation (GO:0001841) | 3.18147036 |
| 66 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.15456671 |
| 67 | positive regulation of defense response to virus by host (GO:0002230) | 3.14471215 |
| 68 | regulation of interleukin-1 secretion (GO:0050704) | 3.10368796 |
| 69 | positive regulation of chemokine biosynthetic process (GO:0045080) | 3.09742122 |
| 70 | granulocyte activation (GO:0036230) | 3.08521293 |
| 71 | virion attachment to host cell (GO:0019062) | 3.06799311 |
| 72 | adhesion of symbiont to host cell (GO:0044650) | 3.06799311 |
| 73 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.06775500 |
| 74 | myeloid cell activation involved in immune response (GO:0002275) | 3.04536571 |
| 75 | respiratory burst (GO:0045730) | 3.04419266 |
| 76 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.01789861 |
| 77 | positive regulation of interleukin-1 beta production (GO:0032731) | 3.01640669 |
| 78 | neutrophil activation (GO:0042119) | 3.01390402 |
| 79 | negative regulation of interleukin-17 production (GO:0032700) | 3.00604652 |
| 80 | behavioral response to nicotine (GO:0035095) | 2.99591563 |
| 81 | leukocyte mediated cytotoxicity (GO:0001909) | 2.98225410 |
| 82 | myeloid leukocyte mediated immunity (GO:0002444) | 2.97861741 |
| 83 | negative regulation of acute inflammatory response (GO:0002674) | 2.97489115 |
| 84 | positive regulation of oligodendrocyte differentiation (GO:0048714) | 2.96625518 |
| 85 | regulation of memory T cell differentiation (GO:0043380) | 2.95937125 |
| 86 | positive regulation of actin filament depolymerization (GO:0030836) | 2.95638510 |
| 87 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.90731493 |
| 88 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 2.89919027 |
| 89 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 2.89459185 |
| 90 | positive regulation of B cell differentiation (GO:0045579) | 2.88859067 |
| 91 | regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645) | 2.85843677 |
| 92 | RNA destabilization (GO:0050779) | 2.85501354 |
| 93 | positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725) | 2.85484314 |
| 94 | response to lipoprotein particle (GO:0055094) | 2.84883938 |
| 95 | negative regulation of cell killing (GO:0031342) | 2.84483526 |
| 96 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.84483526 |
| 97 | modification by symbiont of host morphology or physiology (GO:0044003) | 2.81973036 |
| 98 | mitotic cell cycle arrest (GO:0071850) | 2.81651607 |
| 99 | regulation of T-helper 1 type immune response (GO:0002825) | 2.79357749 |
| 100 | immunoglobulin mediated immune response (GO:0016064) | 2.78597527 |
| 101 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.76508532 |
| 102 | adaptation of signaling pathway (GO:0023058) | 2.76374119 |
| 103 | positive regulation of protein homooligomerization (GO:0032464) | 2.75225762 |
| 104 | cellular response to ATP (GO:0071318) | 2.74513216 |
| 105 | regulation of alkaline phosphatase activity (GO:0010692) | 2.74512366 |
| 106 | positive regulation of humoral immune response (GO:0002922) | 2.74362470 |
| 107 | positive regulation of interferon-beta production (GO:0032728) | 2.72172704 |
| 108 | sulfation (GO:0051923) | 2.72170681 |
| 109 | positive regulation of interleukin-1 production (GO:0032732) | 2.71972281 |
| 110 | interferon-gamma production (GO:0032609) | 2.71476958 |
| 111 | protein kinase C signaling (GO:0070528) | 2.71475521 |
| 112 | macrophage activation (GO:0042116) | 2.71265186 |
| 113 | leukocyte aggregation (GO:0070486) | 2.70746476 |
| 114 | myeloid cell homeostasis (GO:0002262) | 2.70660806 |
| 115 | cornea development in camera-type eye (GO:0061303) | 2.70493821 |
| 116 | positive regulation of antigen processing and presentation (GO:0002579) | 2.70315239 |
| 117 | regulation of chronic inflammatory response (GO:0002676) | 2.70136400 |
| 118 | cellular biogenic amine catabolic process (GO:0042402) | 2.69762994 |
| 119 | amine catabolic process (GO:0009310) | 2.69762994 |
| 120 | hydrogen peroxide biosynthetic process (GO:0050665) | 2.69526046 |
| 121 | platelet dense granule organization (GO:0060155) | 2.69393557 |
| 122 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.69383116 |
| 123 | eosinophil chemotaxis (GO:0048245) | 2.69136599 |
| 124 | myeloid dendritic cell differentiation (GO:0043011) | 2.69092034 |
| 125 | regulation of prostaglandin secretion (GO:0032306) | 2.69052250 |
| 126 | negative regulation of NF-kappaB import into nucleus (GO:0042347) | 2.68755142 |
| 127 | macroautophagy (GO:0016236) | 2.67850572 |
| 128 | fucose catabolic process (GO:0019317) | 2.65820785 |
| 129 | L-fucose metabolic process (GO:0042354) | 2.65820785 |
| 130 | L-fucose catabolic process (GO:0042355) | 2.65820785 |
| 131 | B cell receptor signaling pathway (GO:0050853) | 2.65601178 |
| 132 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 2.65137562 |
| 133 | regulation of interleukin-17 production (GO:0032660) | 2.64596924 |
| 134 | cellular response to molecule of bacterial origin (GO:0071219) | 2.64567589 |
| 135 | positive regulation of fatty acid transport (GO:2000193) | 2.64559366 |
| 136 | T-helper cell differentiation (GO:0042093) | 2.64475979 |
| 137 | CD4-positive, alpha-beta T cell differentiation involved in immune response (GO:0002294) | 2.64475979 |
| 138 | regulation of interleukin-12 production (GO:0032655) | 2.63468938 |
| 139 | cell wall macromolecule catabolic process (GO:0016998) | 2.60885961 |
| 140 | positive regulation of cAMP-mediated signaling (GO:0043950) | 2.55700126 |
| 141 | detection of light stimulus involved in visual perception (GO:0050908) | 2.50731793 |
| 142 | detection of light stimulus involved in sensory perception (GO:0050962) | 2.50731793 |
| 143 | indole-containing compound metabolic process (GO:0042430) | 2.49309731 |
| 144 | positive regulation of icosanoid secretion (GO:0032305) | 2.48946227 |
| 145 | negative regulation of systemic arterial blood pressure (GO:0003085) | 2.48765443 |
| 146 | limb bud formation (GO:0060174) | 2.47639720 |
| 147 | T cell differentiation involved in immune response (GO:0002292) | 2.47506109 |
| 148 | alpha-beta T cell differentiation involved in immune response (GO:0002293) | 2.47506109 |
| 149 | alpha-beta T cell activation involved in immune response (GO:0002287) | 2.47506109 |
| 150 | eosinophil migration (GO:0072677) | 2.46239215 |
| 151 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 2.42802564 |
| 152 | negative regulation of T-helper cell differentiation (GO:0045623) | 2.42802564 |
| 153 | keratinocyte development (GO:0003334) | 2.41220292 |
| 154 | positive regulation of osteoclast differentiation (GO:0045672) | 2.40203871 |
| 155 | endoderm formation (GO:0001706) | 2.40172157 |
| 156 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.40091236 |
| 157 | mast cell activation (GO:0045576) | 2.39673719 |
| 158 | negative regulation of interleukin-12 production (GO:0032695) | 2.39167081 |
| 159 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 2.39096329 |
| 160 | cell wall macromolecule metabolic process (GO:0044036) | 2.34956007 |
| 161 | cellular response to exogenous dsRNA (GO:0071360) | 2.34007723 |
| 162 | somite development (GO:0061053) | 2.33843058 |
| 163 | glial cell proliferation (GO:0014009) | 2.33583453 |
| 164 | positive regulation of glomerulus development (GO:0090193) | 2.33305572 |
| 165 | embryonic epithelial tube formation (GO:0001838) | 2.31400018 |
| 166 | rRNA catabolic process (GO:0016075) | 2.30750617 |
| 167 | response to xenobiotic stimulus (GO:0009410) | 2.30560189 |
| 168 | activated T cell proliferation (GO:0050798) | 2.30198934 |
| 169 | regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370) | 2.29373992 |
| 170 | negative regulation of protein oligomerization (GO:0032460) | 2.28674052 |
| 171 | negative regulation of inflammatory response to antigenic stimulus (GO:0002862) | 2.28307750 |
| 172 | regulation of inflammatory response to antigenic stimulus (GO:0002861) | 2.26355957 |
| 173 | prostate gland growth (GO:0060736) | 2.25748118 |
| 174 | aromatic amino acid family catabolic process (GO:0009074) | 2.25401598 |
| 175 | cellular response to ethanol (GO:0071361) | 2.25124500 |
| 176 | protein localization to cilium (GO:0061512) | 2.24534567 |
| 177 | alpha-beta T cell differentiation (GO:0046632) | 2.24433142 |
| 178 | positive regulation of inflammatory response to antigenic stimulus (GO:0002863) | 2.24208985 |
| 179 | proline transport (GO:0015824) | 2.23887832 |
| 180 | regulation of collateral sprouting (GO:0048670) | 2.23031020 |
| 181 | regulation of mast cell activation (GO:0033003) | 2.22761921 |
| 182 | preassembly of GPI anchor in ER membrane (GO:0016254) | 2.22317837 |
| 183 | regulation of T-helper cell differentiation (GO:0045622) | 2.20936635 |
| 184 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 2.20455471 |
| 185 | benzene-containing compound metabolic process (GO:0042537) | 2.19646345 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 5.27419835 |
| 2 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 5.20171674 |
| 3 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.75722896 |
| 4 | * Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 4.17825927 |
| 5 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.98353424 |
| 6 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.77161976 |
| 7 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.11620566 |
| 8 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.06214469 |
| 9 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.92855010 |
| 10 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.78785812 |
| 11 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.61519838 |
| 12 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 2.58288389 |
| 13 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.53384371 |
| 14 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.49541158 |
| 15 | ZNF274_21170338_ChIP-Seq_K562_Hela | 2.46843068 |
| 16 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.46607012 |
| 17 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.41316668 |
| 18 | VDR_22108803_ChIP-Seq_LS180_Human | 2.38256708 |
| 19 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.37941635 |
| 20 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.36567304 |
| 21 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.36396389 |
| 22 | VDR_24787735_ChIP-Seq_THP-1_Human | 2.35943193 |
| 23 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.29977121 |
| 24 | IGF1R_20145208_ChIP-Seq_DFB_Human | 2.25702348 |
| 25 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 2.15476322 |
| 26 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.13028815 |
| 27 | * PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 2.04081485 |
| 28 | SPI1_23127762_ChIP-Seq_K562_Human | 1.96997421 |
| 29 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.93740701 |
| 30 | * PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.89827194 |
| 31 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.88814150 |
| 32 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.84549794 |
| 33 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.81599386 |
| 34 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.81238840 |
| 35 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.78531503 |
| 36 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.75670603 |
| 37 | * P300_19829295_ChIP-Seq_ESCs_Human | 1.75523919 |
| 38 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.74828391 |
| 39 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.74408928 |
| 40 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.59494052 |
| 41 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.57640637 |
| 42 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.56226390 |
| 43 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.55793921 |
| 44 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.55704458 |
| 45 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.55694758 |
| 46 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.53973197 |
| 47 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.53067279 |
| 48 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.51824853 |
| 49 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.51390013 |
| 50 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.51390013 |
| 51 | * PU_27001747_Chip-Seq_BMDM_Mouse | 1.50413699 |
| 52 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.49165220 |
| 53 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.47394606 |
| 54 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.46932742 |
| 55 | AR_25329375_ChIP-Seq_VCAP_Human | 1.40217182 |
| 56 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.39712731 |
| 57 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.39550710 |
| 58 | EWS_26573619_Chip-Seq_HEK293_Human | 1.39368129 |
| 59 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.38114160 |
| 60 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.36407083 |
| 61 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.36219498 |
| 62 | * SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.36151419 |
| 63 | * UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.35776714 |
| 64 | * SMAD4_21799915_ChIP-Seq_A2780_Human | 1.31683523 |
| 65 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.31391258 |
| 66 | * SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.30148043 |
| 67 | * SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.29946180 |
| 68 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.26716359 |
| 69 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.26452300 |
| 70 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.25589875 |
| 71 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.25423125 |
| 72 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.24844491 |
| 73 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.24590175 |
| 74 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.23996613 |
| 75 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.23996613 |
| 76 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.22467751 |
| 77 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.21938608 |
| 78 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.21557969 |
| 79 | * MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.21089618 |
| 80 | * EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.20801474 |
| 81 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.20120296 |
| 82 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.19958950 |
| 83 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.19758999 |
| 84 | * PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.19642901 |
| 85 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 1.19347162 |
| 86 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.19271610 |
| 87 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.18830378 |
| 88 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.18210695 |
| 89 | FUS_26573619_Chip-Seq_HEK293_Human | 1.17716468 |
| 90 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.16493383 |
| 91 | * EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.16388243 |
| 92 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.16083586 |
| 93 | STAT3_23295773_ChIP-Seq_U87_Human | 1.15196211 |
| 94 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.13698678 |
| 95 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.13660699 |
| 96 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.12995784 |
| 97 | TCF4_23295773_ChIP-Seq_U87_Human | 1.12858835 |
| 98 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.12464127 |
| 99 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 1.12183645 |
| 100 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.12115603 |
| 101 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.11084482 |
| 102 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.11079824 |
| 103 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.10678322 |
| 104 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.10329209 |
| 105 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.10113513 |
| 106 | * PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.09184391 |
| 107 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 1.09066879 |
| 108 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.08716202 |
| 109 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.06990390 |
| 110 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.06990390 |
| 111 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 1.05946838 |
| 112 | MYB_26560356_Chip-Seq_TH2_Human | 1.05428554 |
| 113 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 1.05297653 |
| 114 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.05173430 |
| 115 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.04746382 |
| 116 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.04248762 |
| 117 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.04248762 |
| 118 | * TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.04110846 |
| 119 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.03840485 |
| 120 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.03144318 |
| 121 | GATA1_22025678_ChIP-Seq_K562_Human | 1.03122353 |
| 122 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.01725087 |
| 123 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.01681643 |
| 124 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.00744789 |
| 125 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.00231373 |
| 126 | * RUNX2_22187159_ChIP-Seq_PCA_Human | 0.99732089 |
| 127 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.99714611 |
| 128 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 0.99526186 |
| 129 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 0.99354576 |
| 130 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.98628097 |
| 131 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.98578580 |
| 132 | RXR_22108803_ChIP-Seq_LS180_Human | 0.97293425 |
| 133 | REST_21632747_ChIP-Seq_MESCs_Mouse | 0.96828072 |
| 134 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.96171742 |
| 135 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.93978887 |
| 136 | * AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.93860973 |
| 137 | TP53_16413492_ChIP-PET_HCT116_Human | 0.92413419 |
| 138 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 0.91707690 |
| 139 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.91626926 |
| 140 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.90352713 |
| 141 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.89427355 |
| 142 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 0.88946467 |
| 143 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.88627295 |
| 144 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 0.86850387 |
| 145 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.86698669 |
| 146 | * ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.86533565 |
| 147 | * MYB_26560356_Chip-Seq_TH1_Human | 0.86225742 |
| 148 | GATA3_27048872_Chip-Seq_THYMUS_Human | 0.86085362 |
| 149 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.86018104 |
| 150 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.85851733 |
| 151 | MAF_26560356_Chip-Seq_TH1_Human | 0.85405936 |
| 152 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.84744977 |
| 153 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.83647016 |
| 154 | GBX2_23144817_ChIP-Seq_PC3_Human | 0.83476484 |
| 155 | * GATA2_19941826_ChIP-Seq_K562_Human | 0.83089952 |
| 156 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.82655247 |
| 157 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.82179730 |
| 158 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.81280905 |
| 159 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.80817445 |
| 160 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.80729099 |
| 161 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.80164956 |
| 162 | * GATA3_26560356_Chip-Seq_TH2_Human | 0.79965324 |
| 163 | CJUN_26792858_Chip-Seq_BT549_Human | 0.78436609 |
| 164 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.76461946 |
| 165 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.75940129 |
| 166 | DROSHA_22980978_ChIP-Seq_HELA_Human | 0.75776279 |
| 167 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.75244679 |
| 168 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.74985617 |
| 169 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.74968975 |
| 170 | AR_21572438_ChIP-Seq_LNCaP_Human | 0.74912884 |
| 171 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.74600782 |
| 172 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.74368573 |
| 173 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.73157604 |
| 174 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.72759275 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0000569_abnormal_digit_pigmentation | 6.45714852 |
| 2 | MP0001835_abnormal_antigen_presentation | 3.80590989 |
| 3 | MP0009278_abnormal_bone_marrow | 3.41032766 |
| 4 | MP0003303_peritoneal_inflammation | 3.16434740 |
| 5 | MP0004510_myositis | 3.11007564 |
| 6 | MP0003172_abnormal_lysosome_physiology | 3.01790401 |
| 7 | MP0003436_decreased_susceptibility_to | 3.00134560 |
| 8 | MP0002419_abnormal_innate_immunity | 2.98414131 |
| 9 | MP0005000_abnormal_immune_tolerance | 2.85550346 |
| 10 | MP0005058_abnormal_lysosome_morphology | 2.84217467 |
| 11 | MP0002148_abnormal_hypersensitivity_rea | 2.57181475 |
| 12 | MP0004947_skin_inflammation | 2.56524703 |
| 13 | MP0001800_abnormal_humoral_immune | 2.56060536 |
| 14 | MP0005387_immune_system_phenotype | 2.53872309 |
| 15 | MP0001790_abnormal_immune_system | 2.53872309 |
| 16 | MP0002452_abnormal_antigen_presenting | 2.51186967 |
| 17 | MP0003787_abnormal_imprinting | 2.50723661 |
| 18 | MP0003183_abnormal_peptide_metabolism | 2.49276014 |
| 19 | MP0009785_altered_susceptibility_to | 2.44526393 |
| 20 | MP0005025_abnormal_response_to | 2.42100865 |
| 21 | MP0002723_abnormal_immune_serum | 2.36775877 |
| 22 | MP0005174_abnormal_tail_pigmentation | 2.33902903 |
| 23 | MP0006082_CNS_inflammation | 2.31951503 |
| 24 | MP0005464_abnormal_platelet_physiology | 2.23683139 |
| 25 | MP0000685_abnormal_immune_system | 2.21832868 |
| 26 | MP0002837_dystrophic_cardiac_calcinosis | 2.19541799 |
| 27 | MP0002139_abnormal_hepatobiliary_system | 2.15576071 |
| 28 | MP0008875_abnormal_xenobiotic_pharmacok | 2.04481690 |
| 29 | MP0001819_abnormal_immune_cell | 1.97459059 |
| 30 | MP0002420_abnormal_adaptive_immunity | 1.95962720 |
| 31 | MP0008877_abnormal_DNA_methylation | 1.94077971 |
| 32 | MP0006072_abnormal_retinal_apoptosis | 1.86153576 |
| 33 | MP0000604_amyloidosis | 1.85946609 |
| 34 | MP0005646_abnormal_pituitary_gland | 1.83637825 |
| 35 | MP0005671_abnormal_response_to | 1.83258442 |
| 36 | MP0003300_gastrointestinal_ulcer | 1.80160280 |
| 37 | MP0002254_reproductive_system_inflammat | 1.79858747 |
| 38 | MP0000015_abnormal_ear_pigmentation | 1.78348658 |
| 39 | MP0003724_increased_susceptibility_to | 1.73864642 |
| 40 | MP0002876_abnormal_thyroid_physiology | 1.73830934 |
| 41 | MP0003690_abnormal_glial_cell | 1.73651592 |
| 42 | MP0001853_heart_inflammation | 1.71653099 |
| 43 | MP0003646_muscle_fatigue | 1.68118538 |
| 44 | MP0003448_altered_tumor_morphology | 1.68019866 |
| 45 | MP0005397_hematopoietic_system_phenotyp | 1.67675459 |
| 46 | MP0001545_abnormal_hematopoietic_system | 1.67675459 |
| 47 | MP0009764_decreased_sensitivity_to | 1.62964985 |
| 48 | MP0009840_abnormal_foam_cell | 1.56416516 |
| 49 | MP0005551_abnormal_eye_electrophysiolog | 1.56179126 |
| 50 | MP0001845_abnormal_inflammatory_respons | 1.48666587 |
| 51 | MP0010386_abnormal_urinary_bladder | 1.48665365 |
| 52 | MP0008260_abnormal_autophagy | 1.48566141 |
| 53 | MP0002405_respiratory_system_inflammati | 1.46922170 |
| 54 | MP0005253_abnormal_eye_physiology | 1.46724139 |
| 55 | MP0005167_abnormal_blood-brain_barrier | 1.45861665 |
| 56 | MP0004885_abnormal_endolymph | 1.42907191 |
| 57 | MP0001533_abnormal_skeleton_physiology | 1.40640330 |
| 58 | MP0001851_eye_inflammation | 1.36734820 |
| 59 | MP0008469_abnormal_protein_level | 1.32691167 |
| 60 | MP0000716_abnormal_immune_system | 1.30890448 |
| 61 | MP0001968_abnormal_touch/_nociception | 1.28243794 |
| 62 | MP0002102_abnormal_ear_morphology | 1.28154286 |
| 63 | MP0002006_tumorigenesis | 1.25360609 |
| 64 | MP0010155_abnormal_intestine_physiology | 1.25120710 |
| 65 | MP0003075_altered_response_to | 1.24472284 |
| 66 | MP0003191_abnormal_cellular_cholesterol | 1.24297701 |
| 67 | MP0000920_abnormal_myelination | 1.23736474 |
| 68 | MP0005310_abnormal_salivary_gland | 1.20320574 |
| 69 | MP0002398_abnormal_bone_marrow | 1.18693145 |
| 70 | MP0003011_delayed_dark_adaptation | 1.18159509 |
| 71 | MP0009745_abnormal_behavioral_response | 1.17772430 |
| 72 | MP0003453_abnormal_keratinocyte_physiol | 1.17367181 |
| 73 | MP0000371_diluted_coat_color | 1.16417615 |
| 74 | MP0000689_abnormal_spleen_morphology | 1.15226807 |
| 75 | MP0003880_abnormal_central_pattern | 1.11638349 |
| 76 | MP0008872_abnormal_physiological_respon | 1.09817675 |
| 77 | MP0002272_abnormal_nervous_system | 1.09483855 |
| 78 | MP0002998_abnormal_bone_remodeling | 1.07098807 |
| 79 | MP0003091_abnormal_cell_migration | 1.06337889 |
| 80 | MP0004924_abnormal_behavior | 1.05611072 |
| 81 | MP0005386_behavior/neurological_phenoty | 1.05611072 |
| 82 | MP0005647_abnormal_sex_gland | 1.05572760 |
| 83 | MP0004381_abnormal_hair_follicle | 1.04557113 |
| 84 | MP0002166_altered_tumor_susceptibility | 1.04241005 |
| 85 | MP0002138_abnormal_hepatobiliary_system | 1.03629463 |
| 86 | MP0003828_pulmonary_edema | 1.02770367 |
| 87 | MP0005365_abnormal_bile_salt | 1.01930941 |
| 88 | MP0002653_abnormal_ependyma_morphology | 1.00942705 |
| 89 | MP0009763_increased_sensitivity_to | 0.98948369 |
| 90 | MP0002693_abnormal_pancreas_physiology | 0.98368023 |
| 91 | MP0002429_abnormal_blood_cell | 0.97131527 |
| 92 | MP0001486_abnormal_startle_reflex | 0.96324212 |
| 93 | MP0001986_abnormal_taste_sensitivity | 0.95244130 |
| 94 | MP0002009_preneoplasia | 0.95071438 |
| 95 | MP0000343_altered_response_to | 0.94907880 |
| 96 | MP0001873_stomach_inflammation | 0.94251023 |
| 97 | MP0003566_abnormal_cell_adhesion | 0.93954565 |
| 98 | MP0001958_emphysema | 0.93872474 |
| 99 | MP0002933_joint_inflammation | 0.90339308 |
| 100 | MP0004043_abnormal_pH_regulation | 0.89962209 |
| 101 | MP0000858_altered_metastatic_potential | 0.89851934 |
| 102 | MP0005076_abnormal_cell_differentiation | 0.88784639 |
| 103 | MP0002722_abnormal_immune_system | 0.88599873 |
| 104 | MP0000465_gastrointestinal_hemorrhage | 0.88238291 |
| 105 | MP0001764_abnormal_homeostasis | 0.86167128 |
| 106 | MP0009765_abnormal_xenobiotic_induced | 0.85821579 |
| 107 | MP0001970_abnormal_pain_threshold | 0.83935545 |
| 108 | MP0001919_abnormal_reproductive_system | 0.83921301 |
| 109 | MP0005257_abnormal_intraocular_pressure | 0.83916668 |
| 110 | MP0002735_abnormal_chemical_nociception | 0.83302817 |
| 111 | MP0008995_early_reproductive_senescence | 0.81098289 |
| 112 | MP0005166_decreased_susceptibility_to | 0.80572815 |
| 113 | MP0001984_abnormal_olfaction | 0.80162859 |
| 114 | MP0002064_seizures | 0.79824535 |
| 115 | MP0002733_abnormal_thermal_nociception | 0.78924092 |
| 116 | MP0000249_abnormal_blood_vessel | 0.78794580 |
| 117 | MP0000372_irregular_coat_pigmentation | 0.78722798 |
| 118 | MP0002638_abnormal_pupillary_reflex | 0.77662205 |
| 119 | MP0003634_abnormal_glial_cell | 0.77181945 |
| 120 | MP0000383_abnormal_hair_follicle | 0.77160145 |
| 121 | MP0004142_abnormal_muscle_tone | 0.76869348 |
| 122 | MP0003763_abnormal_thymus_physiology | 0.75983962 |
| 123 | MP0000230_abnormal_systemic_arterial | 0.75196446 |
| 124 | MP0001765_abnormal_ion_homeostasis | 0.74171603 |
| 125 | MP0005379_endocrine/exocrine_gland_phen | 0.73589372 |
| 126 | MP0002736_abnormal_nociception_after | 0.73515988 |
| 127 | MP0001485_abnormal_pinna_reflex | 0.73179929 |
| 128 | MP0004742_abnormal_vestibular_system | 0.72800471 |
| 129 | MP0002163_abnormal_gland_morphology | 0.72321184 |
| 130 | MP0003633_abnormal_nervous_system | 0.71916041 |
| 131 | MP0005164_abnormal_response_to | 0.71315685 |
| 132 | MP0003252_abnormal_bile_duct | 0.71268379 |
| 133 | MP0003879_abnormal_hair_cell | 0.70560691 |
| 134 | MP0003656_abnormal_erythrocyte_physiolo | 0.69989122 |
| 135 | MP0001440_abnormal_grooming_behavior | 0.68103516 |
| 136 | MP0002277_abnormal_respiratory_mucosa | 0.65686851 |
| 137 | MP0005075_abnormal_melanosome_morpholog | 0.64965563 |
| 138 | MP0005197_abnormal_uvea_morphology | 0.62218427 |
| 139 | MP0005408_hypopigmentation | 0.62111839 |
| 140 | MP0001501_abnormal_sleep_pattern | 0.60664326 |
| 141 | MP0004883_abnormal_blood_vessel | 0.59985393 |
| 142 | MP0002332_abnormal_exercise_endurance | 0.59689600 |
| 143 | MP0003195_calcinosis | 0.55889704 |
| 144 | MP0003866_abnormal_defecation | 0.55702429 |
| 145 | MP0009333_abnormal_splenocyte_physiolog | 0.54938019 |
| 146 | MP0002075_abnormal_coat/hair_pigmentati | 0.54655038 |
| 147 | MP0005390_skeleton_phenotype | 0.54242760 |
| 148 | MP0010678_abnormal_skin_adnexa | 0.53164150 |
| 149 | MP0001191_abnormal_skin_condition | 0.51954506 |
| 150 | MP0002090_abnormal_vision | 0.50879248 |
| 151 | MP0009046_muscle_twitch | 0.50773313 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Stomatitis (HP:0010280) | 7.26903847 |
| 2 | Recurrent bacterial skin infections (HP:0005406) | 7.01378421 |
| 3 | Recurrent abscess formation (HP:0002722) | 6.95759413 |
| 4 | Elevated erythrocyte sedimentation rate (HP:0003565) | 6.78095574 |
| 5 | Eczematoid dermatitis (HP:0000976) | 5.39878995 |
| 6 | Amyloidosis (HP:0011034) | 5.24064585 |
| 7 | Recurrent gram-negative bacterial infections (HP:0005420) | 4.81863484 |
| 8 | Mediastinal lymphadenopathy (HP:0100721) | 4.67460921 |
| 9 | Thick nail (HP:0001805) | 4.63921706 |
| 10 | Recurrent skin infections (HP:0001581) | 4.36472236 |
| 11 | Prostate neoplasm (HP:0100787) | 4.30351395 |
| 12 | Abnormality of macrophages (HP:0004311) | 4.22656739 |
| 13 | Gingivitis (HP:0000230) | 3.97665541 |
| 14 | Increased cerebral lipofuscin (HP:0011813) | 3.95308597 |
| 15 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.71941427 |
| 16 | Vasculitis (HP:0002633) | 3.66769352 |
| 17 | Retrobulbar optic neuritis (HP:0100654) | 3.61219029 |
| 18 | Optic neuritis (HP:0100653) | 3.61219029 |
| 19 | Periodontitis (HP:0000704) | 3.56215439 |
| 20 | Orchitis (HP:0100796) | 3.41237422 |
| 21 | Congenital stationary night blindness (HP:0007642) | 3.36660365 |
| 22 | Hematochezia (HP:0002573) | 3.36530868 |
| 23 | Leukocytosis (HP:0001974) | 3.33727834 |
| 24 | Vacuolated lymphocytes (HP:0001922) | 3.31910899 |
| 25 | Abolished electroretinogram (ERG) (HP:0000550) | 3.30715409 |
| 26 | Recurrent fungal infections (HP:0002841) | 3.29420926 |
| 27 | Pancreatic cysts (HP:0001737) | 3.26122918 |
| 28 | Progressive sensorineural hearing impairment (HP:0000408) | 3.25641301 |
| 29 | Myositis (HP:0100614) | 3.14607655 |
| 30 | Progressive hearing impairment (HP:0001730) | 2.93355471 |
| 31 | Submucous cleft hard palate (HP:0000176) | 2.90888466 |
| 32 | Urticaria (HP:0001025) | 2.88749412 |
| 33 | Axonal loss (HP:0003447) | 2.88162876 |
| 34 | Episodic fever (HP:0001954) | 2.80824602 |
| 35 | Recurrent cutaneous fungal infections (HP:0011370) | 2.78033713 |
| 36 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.78033713 |
| 37 | Premature loss of primary teeth (HP:0006323) | 2.76808139 |
| 38 | Chronic obstructive pulmonary disease (HP:0006510) | 2.74726452 |
| 39 | Obstructive lung disease (HP:0006536) | 2.74726452 |
| 40 | IgG deficiency (HP:0004315) | 2.74192245 |
| 41 | Pulmonary infiltrates (HP:0002113) | 2.72936260 |
| 42 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.72505410 |
| 43 | Colitis (HP:0002583) | 2.72454052 |
| 44 | Gingival bleeding (HP:0000225) | 2.72092167 |
| 45 | Large earlobe (HP:0009748) | 2.71750153 |
| 46 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.68820864 |
| 47 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.68820864 |
| 48 | Abnormality of glycolipid metabolism (HP:0010969) | 2.68820864 |
| 49 | True hermaphroditism (HP:0010459) | 2.67020080 |
| 50 | Attenuation of retinal blood vessels (HP:0007843) | 2.66393998 |
| 51 | Pustule (HP:0200039) | 2.66314342 |
| 52 | Autoimmune thrombocytopenia (HP:0001973) | 2.64887704 |
| 53 | Recurrent viral infections (HP:0004429) | 2.62924694 |
| 54 | Abnormal rod and cone electroretinograms (HP:0008323) | 2.61385699 |
| 55 | Restrictive lung disease (HP:0002091) | 2.60475212 |
| 56 | Nephronophthisis (HP:0000090) | 2.60266394 |
| 57 | Pancreatic fibrosis (HP:0100732) | 2.57854302 |
| 58 | Hypothermia (HP:0002045) | 2.57408029 |
| 59 | Congenital sensorineural hearing impairment (HP:0008527) | 2.51920252 |
| 60 | Slow saccadic eye movements (HP:0000514) | 2.49096094 |
| 61 | Pulmonary artery stenosis (HP:0004415) | 2.48308637 |
| 62 | Osteomyelitis (HP:0002754) | 2.46674106 |
| 63 | Systemic lupus erythematosus (HP:0002725) | 2.42731531 |
| 64 | Cellulitis (HP:0100658) | 2.39353981 |
| 65 | Agitation (HP:0000713) | 2.39099839 |
| 66 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 2.36667057 |
| 67 | Myocardial infarction (HP:0001658) | 2.36014957 |
| 68 | Abnormality of eosinophils (HP:0001879) | 2.32898571 |
| 69 | Abnormality of the renal cortex (HP:0011035) | 2.29719045 |
| 70 | Type II lissencephaly (HP:0007260) | 2.24917398 |
| 71 | Pendular nystagmus (HP:0012043) | 2.23695205 |
| 72 | Abnormality of the renal medulla (HP:0100957) | 2.23542518 |
| 73 | Gangrene (HP:0100758) | 2.21807676 |
| 74 | Molar tooth sign on MRI (HP:0002419) | 2.21603121 |
| 75 | Abnormality of midbrain morphology (HP:0002418) | 2.21603121 |
| 76 | Turricephaly (HP:0000262) | 2.21574783 |
| 77 | Joint hemorrhage (HP:0005261) | 2.20750439 |
| 78 | Alveolar cell carcinoma (HP:0006519) | 2.20364132 |
| 79 | Bone pain (HP:0002653) | 2.17812695 |
| 80 | Neoplasm of the tracheobronchial system (HP:0100552) | 2.15591546 |
| 81 | Abnormality of the prostate (HP:0008775) | 2.14406112 |
| 82 | Abnormality of T cell number (HP:0011839) | 2.13459266 |
| 83 | Severe combined immunodeficiency (HP:0004430) | 2.13242467 |
| 84 | Gastrointestinal stroma tumor (HP:0100723) | 2.11650032 |
| 85 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 2.11246090 |
| 86 | Congenital, generalized hypertrichosis (HP:0004540) | 2.10348115 |
| 87 | 3-Methylglutaconic aciduria (HP:0003535) | 2.10151166 |
| 88 | Decreased circulating renin level (HP:0003351) | 2.08625271 |
| 89 | Dysostosis multiplex (HP:0000943) | 2.08602159 |
| 90 | Chronic hepatic failure (HP:0100626) | 2.08294667 |
| 91 | Peripheral demyelination (HP:0011096) | 2.06820706 |
| 92 | Eosinophilia (HP:0001880) | 2.06376792 |
| 93 | Interstitial pulmonary disease (HP:0006530) | 2.04794139 |
| 94 | Absent frontal sinuses (HP:0002688) | 2.04505343 |
| 95 | Decreased central vision (HP:0007663) | 2.02880852 |
| 96 | Polyneuropathy (HP:0001271) | 2.01940233 |
| 97 | Gaze-evoked nystagmus (HP:0000640) | 2.01915696 |
| 98 | Glomerulonephritis (HP:0000099) | 2.01340528 |
| 99 | Recurrent pneumonia (HP:0006532) | 2.00883724 |
| 100 | Hyperventilation (HP:0002883) | 1.99806456 |
| 101 | Febrile seizures (HP:0002373) | 1.97699849 |
| 102 | Arterial thrombosis (HP:0004420) | 1.97663536 |
| 103 | Progressive cerebellar ataxia (HP:0002073) | 1.97451407 |
| 104 | Inflammation of the large intestine (HP:0002037) | 1.97118594 |
| 105 | Furrowed tongue (HP:0000221) | 1.95682640 |
| 106 | Disproportionate short-trunk short stature (HP:0003521) | 1.94690811 |
| 107 | Meningitis (HP:0001287) | 1.92687209 |
| 108 | Anhidrosis (HP:0000970) | 1.92395883 |
| 109 | Generalized hypopigmentation (HP:0007513) | 1.91490278 |
| 110 | Conical tooth (HP:0000698) | 1.91295569 |
| 111 | Widely spaced teeth (HP:0000687) | 1.88431916 |
| 112 | Parakeratosis (HP:0001036) | 1.87514834 |
| 113 | T lymphocytopenia (HP:0005403) | 1.87267975 |
| 114 | Hypophosphatemia (HP:0002148) | 1.87207738 |
| 115 | Erythroderma (HP:0001019) | 1.86802016 |
| 116 | Stomach cancer (HP:0012126) | 1.85822517 |
| 117 | Cystic liver disease (HP:0006706) | 1.85148076 |
| 118 | Distal lower limb amyotrophy (HP:0008944) | 1.84782852 |
| 119 | Keratoconjunctivitis sicca (HP:0001097) | 1.84067186 |
| 120 | Plagiocephaly (HP:0001357) | 1.83507209 |
| 121 | Abnormality of the frontal sinuses (HP:0002687) | 1.83100455 |
| 122 | Disinhibition (HP:0000734) | 1.82958705 |
| 123 | Pathologic fracture (HP:0002756) | 1.82630564 |
| 124 | Clumsiness (HP:0002312) | 1.81495506 |
| 125 | Absent speech (HP:0001344) | 1.81345238 |
| 126 | Renal cortical cysts (HP:0000803) | 1.81112661 |
| 127 | Bony spicule pigmentary retinopathy (HP:0007737) | 1.79701806 |
| 128 | Progressive visual loss (HP:0000529) | 1.79079084 |
| 129 | Abnormality of B cell number (HP:0010975) | 1.78524738 |
| 130 | Frequent falls (HP:0002359) | 1.78219897 |
| 131 | Limb hypertonia (HP:0002509) | 1.77563727 |
| 132 | Long toe (HP:0010511) | 1.76621781 |
| 133 | Hemoptysis (HP:0002105) | 1.75505022 |
| 134 | Thyroiditis (HP:0100646) | 1.75203694 |
| 135 | Supranuclear gaze palsy (HP:0000605) | 1.75176044 |
| 136 | Arthralgia (HP:0002829) | 1.74697008 |
| 137 | Albinism (HP:0001022) | 1.74348140 |
| 138 | Epistaxis (HP:0000421) | 1.73988830 |
| 139 | Depressed nasal tip (HP:0000437) | 1.73783679 |
| 140 | Gastrointestinal inflammation (HP:0004386) | 1.73096197 |
| 141 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.72963308 |
| 142 | Osteolytic defects of the hand bones (HP:0009699) | 1.72963308 |
| 143 | Medial flaring of the eyebrow (HP:0010747) | 1.71560889 |
| 144 | Hepatosplenomegaly (HP:0001433) | 1.71230283 |
| 145 | Polydipsia (HP:0001959) | 1.71138550 |
| 146 | Abnormal drinking behavior (HP:0030082) | 1.71138550 |
| 147 | Macular degeneration (HP:0000608) | 1.70979300 |
| 148 | Keratitis (HP:0000491) | 1.70958276 |
| 149 | Protruding tongue (HP:0010808) | 1.70676959 |
| 150 | Hemiparesis (HP:0001269) | 1.70496719 |
| 151 | Tubular atrophy (HP:0000092) | 1.70328424 |
| 152 | Adactyly (HP:0009776) | 1.70258686 |
| 153 | Male pseudohermaphroditism (HP:0000037) | 1.69820295 |
| 154 | Abnormality of the columella (HP:0009929) | 1.69732646 |
| 155 | Constricted visual fields (HP:0001133) | 1.69482094 |
| 156 | Combined immunodeficiency (HP:0005387) | 1.68754887 |
| 157 | Loss of speech (HP:0002371) | 1.67517694 |
| 158 | Keratoconjunctivitis (HP:0001096) | 1.67416406 |
| 159 | Onion bulb formation (HP:0003383) | 1.67294995 |
| 160 | Pruritus (HP:0000989) | 1.66205162 |
| 161 | Keratoconus (HP:0000563) | 1.65071036 |
| 162 | Increased corneal curvature (HP:0100692) | 1.65071036 |
| 163 | Inability to walk (HP:0002540) | 1.64987146 |
| 164 | Ketosis (HP:0001946) | 1.64032924 |
| 165 | Focal seizures (HP:0007359) | 1.62819836 |
| 166 | Dialeptic seizures (HP:0011146) | 1.62082950 |
| 167 | Encephalitis (HP:0002383) | 1.60749285 |
| 168 | Aplasia/hypoplasia of the uterus (HP:0008684) | 1.58462933 |
| 169 | Photophobia (HP:0000613) | 1.58429984 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FRK | 5.07186014 |
| 2 | MAP3K14 | 4.86777982 |
| 3 | RIPK4 | 4.34728672 |
| 4 | ADRBK2 | 4.27829066 |
| 5 | IRAK3 | 4.12336633 |
| 6 | TBK1 | 3.32191585 |
| 7 | IRAK4 | 3.23974551 |
| 8 | GRK1 | 2.97247589 |
| 9 | IKBKE | 2.89804254 |
| 10 | MAP3K13 | 2.78559822 |
| 11 | MAP4K1 | 2.69901100 |
| 12 | IKBKB | 2.53839433 |
| 13 | TYK2 | 2.49288635 |
| 14 | MAP4K2 | 2.27714913 |
| 15 | TAOK3 | 2.05338165 |
| 16 | DAPK2 | 2.04836525 |
| 17 | BLK | 2.04652331 |
| 18 | ACVR1B | 1.96683817 |
| 19 | CHUK | 1.91108237 |
| 20 | FES | 1.89058412 |
| 21 | TLK1 | 1.88368820 |
| 22 | KIT | 1.87302649 |
| 23 | PINK1 | 1.86815385 |
| 24 | JAK1 | 1.86569483 |
| 25 | TXK | 1.78907800 |
| 26 | FGR | 1.76369100 |
| 27 | MAP3K4 | 1.66343788 |
| 28 | WNK3 | 1.65380447 |
| 29 | CSF1R | 1.59133406 |
| 30 | EPHB1 | 1.57274021 |
| 31 | JAK3 | 1.55314549 |
| 32 | SIK2 | 1.52397248 |
| 33 | TRIM28 | 1.42190937 |
| 34 | HCK | 1.36095830 |
| 35 | CDK12 | 1.33619478 |
| 36 | PKN1 | 1.30592172 |
| 37 | CSK | 1.30336849 |
| 38 | MAP2K2 | 1.28593794 |
| 39 | ZAK | 1.21412266 |
| 40 | MAPK13 | 1.19354742 |
| 41 | NUAK1 | 1.19039491 |
| 42 | TTN | 1.13489096 |
| 43 | SYK | 1.11923229 |
| 44 | TNIK | 1.09518647 |
| 45 | BMPR1B | 1.09233145 |
| 46 | INSRR | 1.08088930 |
| 47 | LCK | 1.03965034 |
| 48 | BMPR2 | 1.03407295 |
| 49 | STK38L | 1.03105500 |
| 50 | PRPF4B | 1.01464649 |
| 51 | SIK3 | 0.96377135 |
| 52 | CAMKK2 | 0.95142235 |
| 53 | GRK6 | 0.93824066 |
| 54 | ZAP70 | 0.91800416 |
| 55 | LYN | 0.91619391 |
| 56 | PLK2 | 0.91008039 |
| 57 | CAMK1G | 0.90320248 |
| 58 | JAK2 | 0.88218526 |
| 59 | MAPK7 | 0.85724818 |
| 60 | TGFBR2 | 0.85397397 |
| 61 | PDGFRB | 0.84437369 |
| 62 | PTK6 | 0.79480871 |
| 63 | EGFR | 0.78595891 |
| 64 | IRAK2 | 0.77531355 |
| 65 | STK24 | 0.77519866 |
| 66 | MARK3 | 0.76591781 |
| 67 | EIF2AK3 | 0.75909843 |
| 68 | PIK3CA | 0.75501633 |
| 69 | ITK | 0.75162191 |
| 70 | ADRBK1 | 0.74340666 |
| 71 | CSNK1G2 | 0.74214928 |
| 72 | MAP2K7 | 0.73433649 |
| 73 | ERBB4 | 0.73170967 |
| 74 | CAMK1D | 0.72673629 |
| 75 | BCR | 0.72514313 |
| 76 | PIM1 | 0.71925021 |
| 77 | SGK1 | 0.71610347 |
| 78 | PRKCQ | 0.70440640 |
| 79 | YES1 | 0.68043881 |
| 80 | DAPK3 | 0.67884242 |
| 81 | PBK | 0.67435586 |
| 82 | CSNK1G3 | 0.66756768 |
| 83 | NEK9 | 0.64982360 |
| 84 | SGK2 | 0.63958328 |
| 85 | EIF2AK2 | 0.63641727 |
| 86 | FYN | 0.62480378 |
| 87 | PHKG2 | 0.62286564 |
| 88 | PHKG1 | 0.62286564 |
| 89 | SGK223 | 0.60748406 |
| 90 | SGK494 | 0.60748406 |
| 91 | ERBB2 | 0.60608617 |
| 92 | MST4 | 0.60566976 |
| 93 | NLK | 0.59820098 |
| 94 | SGK3 | 0.58438374 |
| 95 | MATK | 0.58186151 |
| 96 | GRK7 | 0.58102385 |
| 97 | MKNK2 | 0.57424691 |
| 98 | CASK | 0.57332228 |
| 99 | ABL1 | 0.57319387 |
| 100 | CSNK1G1 | 0.55881837 |
| 101 | MUSK | 0.55803086 |
| 102 | PDPK1 | 0.55713533 |
| 103 | BTK | 0.54602509 |
| 104 | GSK3A | 0.54557741 |
| 105 | PAK3 | 0.53743592 |
| 106 | IGF1R | 0.52782913 |
| 107 | PRKCD | 0.52381646 |
| 108 | MAPKAPK3 | 0.51806663 |
| 109 | PRKCG | 0.51525453 |
| 110 | PDK1 | 0.51389951 |
| 111 | ERN1 | 0.50772741 |
| 112 | RPS6KA4 | 0.50574287 |
| 113 | BCKDK | 0.50444131 |
| 114 | IRAK1 | 0.50157673 |
| 115 | CSNK1A1L | 0.49882501 |
| 116 | MAP2K6 | 0.49038677 |
| 117 | MELK | 0.48418650 |
| 118 | FER | 0.47839852 |
| 119 | CDK6 | 0.45959281 |
| 120 | BRD4 | 0.45652084 |
| 121 | MAP3K10 | 0.43945194 |
| 122 | TYRO3 | 0.42705492 |
| 123 | TAOK1 | 0.39481538 |
| 124 | TNK2 | 0.38980905 |
| 125 | TEC | 0.38501394 |
| 126 | MARK1 | 0.38278497 |
| 127 | DAPK1 | 0.37887140 |
| 128 | INSR | 0.37887087 |
| 129 | MAPK10 | 0.37579054 |
| 130 | CSNK1A1 | 0.37465970 |
| 131 | MAPK15 | 0.36685830 |
| 132 | FGFR2 | 0.35126318 |
| 133 | PRKCE | 0.34809524 |
| 134 | PDK2 | 0.34362213 |
| 135 | CAMK2A | 0.33881174 |
| 136 | MAP3K9 | 0.33846651 |
| 137 | STK10 | 0.33441922 |
| 138 | MAP3K5 | 0.32970265 |
| 139 | FGFR3 | 0.32550547 |
| 140 | CLK1 | 0.31231292 |
| 141 | EPHA3 | 0.30689444 |
| 142 | MAPK12 | 0.29934359 |
| 143 | ERBB3 | 0.29877837 |
| 144 | BMX | 0.29814649 |
| 145 | STK39 | 0.29111286 |
| 146 | EPHA4 | 0.28784055 |
| 147 | TRPM7 | 0.28281665 |
| 148 | OXSR1 | 0.27973676 |
| 149 | RPS6KA6 | 0.27505215 |
| 150 | SIK1 | 0.27467003 |
| 151 | MAPKAPK2 | 0.27227274 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 3.14275712 |
| 2 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.74398958 |
| 3 | Leishmaniasis_Homo sapiens_hsa05140 | 2.73914947 |
| 4 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.63198964 |
| 5 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 2.62321471 |
| 6 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.52534288 |
| 7 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.44726185 |
| 8 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.41545825 |
| 9 | Pertussis_Homo sapiens_hsa05133 | 2.29648530 |
| 10 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.25198426 |
| 11 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 2.22347019 |
| 12 | Phototransduction_Homo sapiens_hsa04744 | 2.15916522 |
| 13 | Malaria_Homo sapiens_hsa05144 | 2.10283984 |
| 14 | TNF signaling pathway_Homo sapiens_hsa04668 | 2.02647878 |
| 15 | Tuberculosis_Homo sapiens_hsa05152 | 2.02323318 |
| 16 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.96373761 |
| 17 | Legionellosis_Homo sapiens_hsa05134 | 1.79978990 |
| 18 | Allograft rejection_Homo sapiens_hsa05330 | 1.78715317 |
| 19 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.76619503 |
| 20 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.75436495 |
| 21 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.74003838 |
| 22 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.72544433 |
| 23 | Influenza A_Homo sapiens_hsa05164 | 1.69113152 |
| 24 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.65521929 |
| 25 | Measles_Homo sapiens_hsa05162 | 1.63486184 |
| 26 | Phagosome_Homo sapiens_hsa04145 | 1.60210179 |
| 27 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.57988477 |
| 28 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.56472521 |
| 29 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.55732600 |
| 30 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.49755134 |
| 31 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.49754609 |
| 32 | Lysosome_Homo sapiens_hsa04142 | 1.48349316 |
| 33 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.47196630 |
| 34 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.46100748 |
| 35 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.45006894 |
| 36 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.44752206 |
| 37 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.43973119 |
| 38 | Apoptosis_Homo sapiens_hsa04210 | 1.43248382 |
| 39 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.38955217 |
| 40 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.37848912 |
| 41 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.37121913 |
| 42 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.36886132 |
| 43 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.35056394 |
| 44 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.32934045 |
| 45 | Asthma_Homo sapiens_hsa05310 | 1.32728145 |
| 46 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.32262238 |
| 47 | Nicotine addiction_Homo sapiens_hsa05033 | 1.30388816 |
| 48 | Shigellosis_Homo sapiens_hsa05131 | 1.29896819 |
| 49 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.29417345 |
| 50 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.28378858 |
| 51 | Salmonella infection_Homo sapiens_hsa05132 | 1.24322010 |
| 52 | Hepatitis C_Homo sapiens_hsa05160 | 1.17938543 |
| 53 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.11011806 |
| 54 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.05760153 |
| 55 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.05616804 |
| 56 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.05489445 |
| 57 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.03055868 |
| 58 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.01507740 |
| 59 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.00341043 |
| 60 | Protein export_Homo sapiens_hsa03060 | 0.97937838 |
| 61 | Hepatitis B_Homo sapiens_hsa05161 | 0.97448032 |
| 62 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.95664367 |
| 63 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.93624518 |
| 64 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.89701238 |
| 65 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.89439330 |
| 66 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.89309485 |
| 67 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.88897426 |
| 68 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.87803255 |
| 69 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.87699460 |
| 70 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.87622274 |
| 71 | Morphine addiction_Homo sapiens_hsa05032 | 0.84528180 |
| 72 | ABC transporters_Homo sapiens_hsa02010 | 0.84287669 |
| 73 | Amoebiasis_Homo sapiens_hsa05146 | 0.82991378 |
| 74 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.81273051 |
| 75 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.80930040 |
| 76 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.80851503 |
| 77 | Retinol metabolism_Homo sapiens_hsa00830 | 0.79654390 |
| 78 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.79362226 |
| 79 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.79134569 |
| 80 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.78493380 |
| 81 | Taste transduction_Homo sapiens_hsa04742 | 0.78139888 |
| 82 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.77310306 |
| 83 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.75594148 |
| 84 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.74812999 |
| 85 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.74659473 |
| 86 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.74124215 |
| 87 | Other glycan degradation_Homo sapiens_hsa00511 | 0.72502236 |
| 88 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.71169966 |
| 89 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.71062107 |
| 90 | Platelet activation_Homo sapiens_hsa04611 | 0.69112764 |
| 91 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.67507224 |
| 92 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.65940606 |
| 93 | Viral myocarditis_Homo sapiens_hsa05416 | 0.65418787 |
| 94 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.64660963 |
| 95 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.64095678 |
| 96 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.63415373 |
| 97 | Olfactory transduction_Homo sapiens_hsa04740 | 0.63172477 |
| 98 | Salivary secretion_Homo sapiens_hsa04970 | 0.62272709 |
| 99 | Mineral absorption_Homo sapiens_hsa04978 | 0.62023180 |
| 100 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.61875208 |
| 101 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.61143644 |
| 102 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.60966529 |
| 103 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.60746282 |
| 104 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.59515365 |
| 105 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.59511637 |
| 106 | Basal transcription factors_Homo sapiens_hsa03022 | 0.58821009 |
| 107 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.58516548 |
| 108 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.58076047 |
| 109 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.57174332 |
| 110 | Insulin resistance_Homo sapiens_hsa04931 | 0.56951482 |
| 111 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.56722941 |
| 112 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.56710137 |
| 113 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.56529325 |
| 114 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.56362044 |
| 115 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.56161038 |
| 116 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.55390085 |
| 117 | Insulin secretion_Homo sapiens_hsa04911 | 0.54348953 |
| 118 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.53361968 |
| 119 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.53272010 |
| 120 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.52711430 |
| 121 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.51121268 |
| 122 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.51029969 |
| 123 | GABAergic synapse_Homo sapiens_hsa04727 | 0.50853095 |
| 124 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.50370160 |
| 125 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.48834668 |
| 126 | Renin secretion_Homo sapiens_hsa04924 | 0.48572985 |
| 127 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.48569913 |
| 128 | Circadian rhythm_Homo sapiens_hsa04710 | 0.48392723 |
| 129 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.47409859 |
| 130 | Circadian entrainment_Homo sapiens_hsa04713 | 0.47096978 |
| 131 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.46573786 |
| 132 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.46258047 |
| 133 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.45951768 |
| 134 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.45939717 |
| 135 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.44431534 |
| 136 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.44161384 |
| 137 | Glioma_Homo sapiens_hsa05214 | 0.43901223 |
| 138 | Histidine metabolism_Homo sapiens_hsa00340 | 0.43321039 |
| 139 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.42287279 |
| 140 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.41373681 |
| 141 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.41176209 |
| 142 | Prion diseases_Homo sapiens_hsa05020 | 0.40193686 |
| 143 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.39588410 |
| 144 | Endocytosis_Homo sapiens_hsa04144 | 0.38666182 |
| 145 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.38127239 |
| 146 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.36727362 |
| 147 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.36102974 |
| 148 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.35902660 |
| 149 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.34662424 |
| 150 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.32266588 |

